To determine whether inactivation of Tcf7 in CD4+ T cells altered the composition of myeloid cells within the PDA TME, we performed unbiased subclustering of myeloid cells from the scRNA-seq data. The gene discussed is TCF7; the disease is Patent ductus arteriosus.